16 July 2025NewsPatentsMichael Shuster, Goodwin Law | Erica LoRe, Invivyd | Guy Birkenmeier, New England Biolabs

WATCH: Patents s101—how to overcome the current complexity of patent eligibility in the US

LSPN experts from Goodwin Law, Invivyd, and New England Biolabs discuss the challenges of patent eligibility under 35 U.S.C. § 101 in life sciences innovation. The session explores strategies to address obstacles arising from recent court decisions and USPTO guidelines.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

Apple v Masimo: Could a Fed Circ decision limit patent cases at the ITC?

Skechers targeted over ‘Slip-in’ shoes' hands-free tech

Beyond Getty: Are trademarks a bigger risk to AI than copyright?

WATCH: China patent landscape—AI, patent linkage, export controls, and more

China bars USPTO employee from leaving country

Emotional Perception: UKIPO conjures The Beatles and Cluedo in pivotal case

SAP, Google, Goodyear: Hot summer cases at the Federal Circuit

WATCH: Enabling success—mastering s112 in the new era of life sciences patents

WATCH: Patents s101—how to overcome the current complexity of patent eligibility in the US

Editor's picks

Editor's picks

More articles